Coloplast A/s Class B · OMXCOP:COLO_B

Coloplast A/s Class B — Investor Day (2014)

14 slides from Coloplast A/s Class B's investor day presentation, 2014

  1. Slide 1: Growth through innovation

    Growth through innovation Coloplast Capital Market Day 2014 Oliver Johansen, SVP Global R&D Page 1

  2. Slide 2: In recent years we have transformed our Global R&D

    In recent years we have transformed our Global R&D Drive growth through 3 Innovation Excellence Raised the bar through our 2 Bigger, Better, Bolder journey Established 1 one Global R&D function 2006 2010 Today Page 2

  3. Slide 3: Our R&D efforts suffered from lack of focus – so we established one Global R&D function

    1 Our R&D efforts suffered from lack of focus – so we established one Global R&D function in response Our observations Our response  We had too many activities driven by range  We established one R&D function for OC, CC care and WC  We had insufficient pipeline value  We established Innovation M

  4. Slide 4: We then raised our innovation ambitions with our Bigger, Better, Bolder journey

    2 We then raised our innovation ambitions with our Bigger, Better, Bolder journey Bigger, Better, Bolder journey highlights:  Fewer innovation projects P1 P2 P3 P4 P5 P6 P7 P8 Product Mechanical Injection  New and upgraded competence centers design construction moulding  Defined launch slots Spri

  5. Slide 5: Today we have a strong point of departure for accelerating growth through Innovation Excellence

    Today we have a strong point of departure for accelerating growth through Innovation Excellence Drive growth through 3 Innovation Excellence Raised the bar through our 2 Bigger, Better, Bolder journey Established 1 one Global R&D function 2006 2010 Today Page 5

  6. Slide 6: Innovation Excellence means three things to us

    Innovation Excellence means three things to us 1 Manage and deliver best new product pipeline ever 2 Ensuring value upgrade through technology development 3 Focus on consumer oriented design and innovation Page 6

  7. Slide 7: Today our innovation begins with a compelling market driven value proposition

    1 Today our innovation begins with a compelling market driven value proposition followed by a structured process Value Front end Product proposition innovation development Page 7

  8. Slide 8: We commit to innovation to make a difference to consumers and to benefit society

    2 We commit to innovation to make a difference to consumers and to benefit society increase in quality of treatment costs reduced 28% life when using compact catheter solutions¹ 40% when using high quality stoma appliances² Source: 1) Chartier-Kastler et al., The Journal of Urology (2013); 2) Martin

  9. Slide 9: Early in our development projects we determine the right pricing strategy

    2 Early in our development projects we determine the right pricing strategy - Coloplast pricing strategy options - Premium pricing  Differentiation Willingness to pay  Documented • Improved quality of life value upgrade • Lower cost of treatment Parity pricing • Improved skin conditions  Lower co

  10. Slide 10: Here is an example of how innovation can make a real difference to our consumers

    2 Here is an example of how innovation can make a real difference to our consumers Page 10

  11. Slide 11: SenSura Mio is a truly groundbreaking product portfolio

    3 SenSura® Mio is a truly groundbreaking product portfolio capturing everything we want in a new ostomy product... New elastic adhesive New all-textile material New full-circle filter New click coupling For secure fit For discretion For less clogging / ballooning For reassurance and security Page 11

  12. Slide 12: Today we are launching our latest innovation in Continence Care: SpeediCath Compact

    3 ...and today we are launching our latest innovation in Continence Care SpeediCath® Compact Attractive stylish Eve consumer design Urine bag for added discretion connector Triangular shape One-step easy Unique hydrophilic for easy handling opening and coating for instant and better grip secure rese

  13. Slide 13: In sum, Global R&D is performing strongly and fuels our growth agenda

    In sum, Global R&D is performing strongly and fuels our growth agenda by delivering the best pipeline ever Drive growth through 3 Innovation Excellence Raised the bar through our 2 Bigger Better Bolder Deliver journey best new pipeline ever Established 1 one Global R&D function 2006 2010 Today Page

  14. Slide 14: Our mission, values and vision

    Our mission Making life easier for people with intimate healthcare needs Our values Closeness... to better understand Passion... to make a difference Respect and responsibility... to guide us Our vision Setting the global standard for listening and responding g Coloplast Page 14

Coloplast — Investor Day (2014) on 6ix